Delivery Order SPE2DB22D3016-SPE2DB25FBDX7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,277.11 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,671.60 to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg on July 23, 2025, with completion expected by July 24, 2025. This firm fixed price delivery order, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tivicay is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $41K to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed price contract type. This award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract valued at $10,353.99. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,159.40 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,295,968 units of the HIV medication Tivicay 50 mg tablets. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
- The Defense Logistics Agency awarded a delivery order valued at $24,055.34 to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 mg tablets (30-count packages) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TIVICAY 50 mg tablets (30-count units) valued at $5,448.89 under a firm fixed-price contract type. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count) valued at $2,871.67 on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency Troop Support Medical awarded a $7,101.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg tablets of Tivicay, an HIV medication. Under the contract, Amerisourcebergen will deliver 30 tablets of Tivicay to a location in Conshohocken, Pennsylvania. The delivery is required to take place between July 17-18, 2023. No subcontractors or set aside designations were identified. The award is likely in support of the Defense Logistics Agency's...
- This federal contract award, valued at $47,433.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Tivicay 50 mg tablets, a medication used to treat HIV/AIDS. The contract has an ultimate completion date of July 24, 2024 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDX7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,334.31 for 30-tablet units of Tivicay 50 mg tablets, a pharmaceutical product used in HIV treatment. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a firm fixed-price transaction with no set-aside designation. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement that extends through December 2026 and provides pharmaceutical and medical supply support to military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains a comprehensive portfolio of competitively awarded federal contracts supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support defense and military healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/4/25 |